| Literature DB >> 33138852 |
Si Yang1,2, Shuai Lin2, Na Li1,2, Yujiao Deng1,2, Meng Wang2, Dong Xiang3, Grace Xiang4, Shuqian Wang1, Xianghua Ye5, Yi Zheng1,2, Jia Yao1, Zhen Zhai1,2, Ying Wu1,2, Jingjing Hu6, Huafeng Kang7, Zhijun Dai8,9.
Abstract
BACKGROUND: The epidemiology of esophageal cancer (EC) can elucidate its causes and risk factors and help develop prevention strategies. We aimed to provide an overview of the burden, trends, and risk factors of EC in China from 1990 to 2017. We also investigated the differences between China, Japan, and South Korea and discussed the possible causes of the disparities.Entities:
Keywords: Death; Disability-adjusted life years; Esophageal cancer; Incidence; Risk factor
Mesh:
Year: 2020 PMID: 33138852 PMCID: PMC7607864 DOI: 10.1186/s13045-020-00981-4
Source DB: PubMed Journal: J Hematol Oncol ISSN: 1756-8722 Impact factor: 17.388
The age-standardized rate and number of esophageal cancer cases in the world, East Asia and Pacific, China, Japan, and South Korea from 1990 to 2017, both sexes
| Variables | World | East Asia and Pacific | China | Japan | South Korea | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1990 | 2017 | Change, % | 1990 | 2017 | Change, % | 1990 | 2017 | Change, % | 1990 | 2017 | Change, % | 1990 | 2017 | Change, % | |
| Incidence rate (per 100,000) | 7.57 (7.33–7.85) | 5.90 (5.74–6.06) | − 22.06 | 13.78 (13.22–14.50) | 9.22 (8.84–9.60) | − 33.07 | 19.38 (18.52–20.50) | 12.23 (11.64–12.82) | − 36.89 | 6.09 (5.99–6.19) | 5.83 (5.52–6.13) | − 4.27 | 5.04 (4.84–5.26) | 3.25 (2.81–3.72) | − 35.52 |
| Incidence numbers | 310,236 (300,690–322,028) | 472,525 (459,485–485,294) | 52.31 | 187,945 (180,252–197,677) | 279,072 (267,563–290,531) | 48.49 | 164,473 (157,194–173,853) | 234,624 (223,240–246,036) | 42.65 | 10,667 (10,485–10,848) | 19,202 (18,203–20,140) | 80.01 | 1,608 (1,541–1,679) | 2,801 (2,414–3,216) | 74.19 |
| Death rate (per 100,000) | 7.72 (7.48–8.01) | 5.48 (5.34–5.63) | − 29.02 | 14.23 (13.63–15.00) | 8.27 (7.95–8.61) | − 41.85 | 20.53 (19.60–21.71) | 11.25 (10.73–11.77) | − 45.20 | 4.47 (4.41–4.53) | 3.66 (3.51–3.81) | − 18.12 | 5.12 (4.92–5.32) | 2.16 (1.92–2.41) | − 57.81 |
| Death numbers | 311,289 (301,451–323,235) | 435,959 (424,994–447,580) | 40.05 | 188,862 (180,759–198,909) | 248,410 (238,407–258,346) | 31.53 | 168,455 (160,933–178,231) | 212,586 (202,673–222,654) | 26.20 | 7,780 (7,673–7,897) | 12,807 (12,310–13,311) | 64.61 | 1,577 (1,515–1,644) | 1,865 (1,653–2,078) | 18.26 |
| DALY rate (per 100,000) | 179.94 (174.09–186.82) | 119.91 (116.89–122.99) | − 33.36 | 314.57 (301.10–331.18) | 169.37 (162.32–176.65) | − 46.16 | 446.42 (425.73–471.70) | 222.58 (211.95–233.57) | − 50.14 | 96.88 (95.43–98.44) | 77.78 (74.47–81.14) | − 19.72 | 124.46 (119.44–129.78) | 44.57 (39.34–50.04) | − 64.19 |
| DALY numbers | 7,677,078 (7,422,100–7,970,949) | 9,777,771 (9,532,791–10,031,497) | 27.36 | 4,582,723 (4,386,849–4,832,515) | 5,262,866 (5,042,535–5,489,756) | 14.84 | 4,078,281 (3,890,143–4,314,430) | 4,464,980 (4,247,816–4,690,846) | 9.48 | 172,127 (169,542–174,893) | 227,447 (218,017–236,700) | 32.14 | 42,870 (41,041–44,820) | 38,988 (34,415–43,822) | − 9.06 |
DALY disability-adjusted life-year
Fig. 1Trends for the ASIR (a), ASDR (b), and age-standardized DALY rate (c) of esophageal cancer in the world, East Asia and Pacific, China, Japan, and South Korea from 1990 to 2017. ASIR age-standardized incidence rate, ASDR age-standardized death rate, DALY disability-adjusted life-year
The age-standardized rate and number of esophageal cancer cases in the world, East Asia and Pacific, China, Japan, and South Korea in 2017, by sex
| Variables | World | East Asia and Pacific | China | Japan | South Korea | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | Male | Female | Male | Female | |
| Incidence rate (per 100,000) | 8.87 (8.55–9.16) | 3.32 (3.17–3.47) | 13.78 (13.05–14.51) | 5.16 (4.79–5.51) | 17.40 (16.30–18.50) | 7.41 (6.80–8.01) | 10.74 (10.12–11.34) | 1.60 (1.50–1.70) | 6.72 (5.79–7.76) | 0.53 (0.46–0.60) |
| Incidence numbers | 330,904 (319,159–341,987) | 141,621 (135,089–147,968) | 197,115 (186,163–207,760) | 81,957 (76,083–87,598) | 162,467 (152,103–172,885) | 72,156 (66,266–78,056) | 16,026 (15,074–16,918) | 3,176 (3,000–3,350) | 2,551 (2,174–2,962) | 250 (218–285) |
| Death rate (per 100,000) | 8.43 (8.15–8.70) | 2.93 (2.81–3.05) | 12.86 (12.19–13.52) | 4.21 (3.94–4.48) | 16.84 (15.83–17.83) | 6.07 (5.61–6.53) | 6.84 (6.54–7.15) | 0.99 (0.95–1.04) | 4.58 (4.03–5.15) | 0.34 (0.31–0.38) |
| Death numbers | 310,733 (300,244–320,551) | 125,226 (120,125–130,421) | 181,557 (171,845–190,879) | 66,852 (62,553–71,159) | 154,391 (144,950–163,636) | 58,196 (53,819–62,609) | 10,611 (10,140–11,098) | 2,196 (2,097–2,294) | 1,698 (1,491–1,913) | 167 (149–187) |
DALY rate (per 100,000) | 184.27 (178.31–190.06) | 60.96 (58.50–63.42) | 266.85 (252.56–280.08) | 78.05 (73.05–83.17) | 341.20 (320.24–361.65) | 107.60 (99.66–115.88) | 141.11 (134.56–147.82) | 20.43 (19.41–21.55) | 89.47 (78.25–100.97) | 6.28 (5.55–7.05) |
| DALY numbers | 7,189,349 (6,956,383–7,415,160) | 2,588,422 (2,483,936–2,693,257) | 4,017,901 (3,801,341–4,219,275) | 1,244,966 (1,165,297–1,327,324) | 3,388,242 (3,176,038–3,594,450) | 1,076,738 (997,302–1,160,383) | 195,357 (186,788–204,307) | 32,090 (30,489–33,731) | 36,117 (31,521–40,880) | 2,870 (2,535–3,214) |
DALY disability-adjusted life-year
Fig. 2Trends for the ASIR and ASDR of esophageal cancer in the world, East Asia and Pacific, China, Japan, and South Korea from 1990 to 2017 calculated by joinpoint regression analyses. a ASIR in China; b ASDR in China; c ASIR in Japan; d ASDR in Japan; e ASIR in South Korea; f ASDR in South Korea; g ASIR in East Asia and Pacific; h ASDR in East Asia and Pacific; i ASIR in the world; j ASDR in the world. ASIR age-standardized incidence rate, ASDR age-standardized death rate
Fig. 3The trend in ASIR (a), ASDR (b), and age-standardized DALY rate (c) of esophageal cancer in the world, China, Japan, and South Korea by socio-demographic index for both sexes combined, 1990 to 2017. Expected values are shown as the black line. ASIR age-standardized incidence rate, ASDR age-standardized death rate, DALY disability-adjusted life-year
DALY number and DALY rate from 1990 to 2017 for esophageal cancer in the 34 provinces of China
| Location name | 1990 | 2017 | ||
|---|---|---|---|---|
| DALY number (in thousands) | DALY rate (per 100,000) | DALY number (in thousands) | DALY rate (per 100,000) | |
| Taiwan | 20.60 (19.90–21.30) | 100.84 (97.57–104.41) | 60.9 (55.9–66.4) | 258.45 (237.20–281.47) |
| Hong Kong SAR | 13.70 (12.30–15.30) | 237.41 (213.36–266.16) | 13.1 (10.8–16.0) | 174.22 (143.59–212.80) |
| Macau SAR | 0.52 (0.47–0.58) | 147.32 (133.12–163.52) | 1.07 (0.86–1.29) | 156.09 (125.26–188.19) |
| Anhui | 296 (258–339) | 499.13 (435.82–571.63) | 262 (220–310) | 429.28 (359.06–507.10) |
| Beijing | 21.5 (18.2–25.1) | 191.80 (162.32–223.77) | 28.6 (22.7–35.1) | 118.47 (94.16–145.56) |
| Chongqing | 71.4 (61–84.3) | 452.71 (386.32–534.06) | 118 (94.5–147) | 441.82 (353.68–551.18) |
| Fujian | 132 (118–151) | 418.79 (371.49–477.83) | 173 (142–211) | 437.82 (359.23–534.46) |
| Gansu | 82.5 (72.4–94.7) | 348.93 (306.16–400.35) | 66.5 (55.2–79.1) | 250.26 (207.61–297.75) |
| Guangdong | 173 (147–205) | 263.28 (222.76–311.34) | 218 (178–265) | 186.24 (152.68–226.75) |
| Guangxi | 50.6 (42.8–60.5) | 116.25 (98.44–139.08) | 58.5 (48.4–70.9) | 121.15 (100.10–146.72) |
| Guizhou | 31.4 (26.3–37.5) | 94.74 (79.32–112.84) | 36.2 (29.6–43.3) | 106.99 (87.50–128.04) |
| Hainan | 8.25 (6.89–9.81) | 118.41 (98.85–140.90) | 8.77 (6.87–11.20) | 91.49 (71.61–116.72) |
| Hebei | 418 (376–461) | 656.86 (590.27–724.88) | 310 (257–368) | 405.15 (336.48–481.29) |
| Heilongjiang | 48.7 (42.5–55.4) | 133.68 (116.57–151.93) | 79.5 (63.9–99.8) | 202.49 (162.73–254.17) |
| Henan | 695 (633–764) | 787.16 (717.65–865.36) | 474 (397–558) | 491.86 (412.39–579.31) |
| Hubei | 122 (109–135) | 218.83 (196.87–242.87) | 173 (145–208) | 313.65 (262.87–375.23) |
| Hunan | 69.3 (61.9–78) | 111.40 (99.48–125.38) | 98.6 (81.3–119) | 146.88 (121.04–177.14) |
| Inner Mongolia | 64.9 (55–76) | 285.55 (241.78–334.12) | 80.5 (66.5–98.1) | 310.88 (256.63–378.71) |
| Jiangsu | 318 (282–358) | 462.56 (410.37–520.59) | 552 (459–654) | 676.15 (561.88–801.22) |
| Jiangxi | 80.5 (71–91.1) | 203.60 (179.53–230.47) | 61.5 (52.3–72.6) | 129.44 (109.99–152.74) |
| Jilin | 28.9 (25.3–33.1) | 111.44 (97.41–127.62) | 37.2 (29.1–45.4) | 133.21 (104.16–162.89) |
| Liaoning | 78.2 (64.7–93.4) | 191.66 (158.54–229.06) | 123 (98.1–152) | 275.46 (219.61–340.01) |
| Ningxia | 9.31 (7.99–10.90) | 188.43 (161.75–220.91) | 12.4 (9.86–15.6) | 176.06 (140.52–221.60) |
| Qinghai | 11.7 (10–13.8) | 246.69 (211.34–290.52) | 15.9 (12.7–19.2) | 252.61 (202.47–305.25) |
| Shaanxi | 65.8 (57.5–74.5) | 191.15 (167.15–216.46) | 122 (97.4–152) | 308.25 (246.48–384.45) |
| Shandong | 351 (305–406) | 410.34 (356.69–473.98) | 386 (318–464) | 388.29 (320.16–466.73) |
| Shanghai | 30.5 (26.4–35.6) | 218.62 (188.78–254.60) | 32.7 (26.3–40.2) | 117.21 (93.98–143.92) |
| Shanxi | 144 (126–164) | 475.81 (416.37–541.29) | 115 (92.3–140) | 298.14 (238.84–363.70) |
| Sichuan | 467 (415–537) | 418.43 (371.91–480.77) | 544 (432–656) | 651.79 (517.97–786.13) |
| Tianjin | 16.1 (13.8–18.4) | 175.51 (150.51–200.17) | 16.4 (13.5–20) | 107.68 (88.45–130.90) |
| Tibet | 3.22 (2.76–3.76) | 138.39 (118.63–161.24) | 2.54 (2.09–3.05) | 73.55 (60.47–88.27) |
| Xinjiang | 42.5 (37.7–47.4) | 269.59 (239.01–300.57) | 74 (61.8–88.8) | 303.72 (253.42–364.52) |
| Yunnan | 34.5 (28.7–42.6) | 88.63 (73.60–109.21) | 48.9 (40.3–60.2) | 99.49 (81.95–122.42) |
| Zhejiang | 97.4 (84.6–113) | 220.93 (191.83–256.76) | 122 (97.7–151) | 200.15 (159.64–246.67) |
DALY disability-adjusted life-year, SAR special administrative region
Fig. 4a The age-standardized DALY rate of esophageal cancer in the 34 provinces of China in 2017. b Age-standardized DALY rate and socio-demographic index in the 34 provinces of China in 2017. DALY disability-adjusted life-year
Fig. 5Percentage of esophageal cancer age-standardized death due to tobacco, alcohol use, high body-mass index, and diet low in fruits in the world, East Asia and Pacific, China, Japan, and South Korea in 1990 and 2017. a For men; b for women
Fig. 6Percentage of esophageal cancer age-standardized DALY rate due to tobacco, alcohol use, high body-mass index, and diet low in fruits in the world, East Asia and Pacific, China, Japan, and South Korea in 1990 and 2017. a For men; b for women. DALY disability-adjusted life-year